Picture of Biomed Lublin Wytwornia Surowic i Szczepionek SA logo

BML — Biomed Lublin Wytwornia Surowic i Szczepionek SA Cashflow Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Biomed Lublin Wytwornia Surowic i Szczepionek SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

C2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
PAS
PAS
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line
Depreciation
Amortisation
Non-Cash Items
Unusual Items
Other Non-Cash Items
Changes in Working Capital
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities
Capital Expenditures
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items
Sale of Fixed Assets
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities
Financing Cash Flow Items
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash

Or unlock with your email

Or unlock with your email